TrialGenetic testing and molecular biomarkers2014

The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study.

Ryo Maruoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.